A Randomized Control Trial Comparing Linjeta Versus Humalog in Pumps: Effect on Postprandial Blood Sugars.
Status:
Withdrawn
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if the use of Linjeta(tm) insulin when compared to
Humalog will result in significantly lower episodes of hyperglycemia and hypoglycemia after a
breakfast meal.
Phase:
Phase 2
Details
Lead Sponsor:
Stanford University
Collaborators:
Biodel University of Colorado Denver School of Medicine Barbara Davis Center